257 related articles for article (PubMed ID: 30615685)
1. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
[TBL] [Abstract][Full Text] [Related]
3. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
[TBL] [Abstract][Full Text] [Related]
5. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
Saha A; Bamidele A; Murakami M; Robertson ES
J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
[TBL] [Abstract][Full Text] [Related]
6. An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.
Pei Y; Banerjee S; Jha HC; Sun Z; Robertson ES
PLoS Pathog; 2017 Jul; 13(7):e1006500. PubMed ID: 28738086
[TBL] [Abstract][Full Text] [Related]
7. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
Jha HC; Lu J; Saha A; Cai Q; Banerjee S; Prasad MA; Robertson ES
J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
Saha A; Halder S; Upadhyay SK; Lu J; Kumar P; Murakami M; Cai Q; Robertson ES
PLoS Pathog; 2011 Feb; 7(2):e1001275. PubMed ID: 21347341
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.
Sahu SK; Mohanty S; Kumar A; Kundu CN; Verma SC; Choudhuri T
Virology; 2014 Jan; 448():333-43. PubMed ID: 24314664
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
Bazot Q; Paschos K; Allday MJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
[TBL] [Abstract][Full Text] [Related]
12. E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.
Saha A; Lu J; Morizur L; Upadhyay SK; Aj MP; Robertson ES
PLoS Pathog; 2012; 8(3):e1002573. PubMed ID: 22438805
[TBL] [Abstract][Full Text] [Related]
13. EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.
Banerjee S; Lu J; Cai Q; Sun Z; Jha HC; Robertson ES
PLoS Pathog; 2014 Aug; 10(8):e1004304. PubMed ID: 25121590
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
[TBL] [Abstract][Full Text] [Related]
15. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
Shukla SK; Jha HC; El-Naccache DW; Robertson ES
Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
Gain C; Malik S; Bhattacharjee S; Ghosh A; Robertson ES; Das BB; Saha A
PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124
[TBL] [Abstract][Full Text] [Related]
17. SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen.
Knight JS; Sharma N; Robertson ES
Mol Cell Biol; 2005 Mar; 25(5):1749-63. PubMed ID: 15713632
[TBL] [Abstract][Full Text] [Related]
18. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
[TBL] [Abstract][Full Text] [Related]
19. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
Yi F; Saha A; Murakami M; Kumar P; Knight JS; Cai Q; Choudhuri T; Robertson ES
Virology; 2009 Jun; 388(2):236-47. PubMed ID: 19394062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
